NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Yes, the data is not complete and has matured by a year a half now. To be statistically significant (in other words, efficacious), you have to unblind the trial, and see how it plays out. And he’s likely not seeing the individual cases of his own patients benefitting from it as Dr. Ashkan, Liau, and some other doctors have seen, most likely because his hospital never enrolled any patients.

From my point of view, I’ve demonstrated to myself at least that the blended data has already beaten Optune’s, so I’m good. I could care less if Dr. Platten isn’t convinced.